BridgeBio Oncology Therapeutics accounting officer Marc Cobo reports sale of 78 shares worth $184.86
BBOT•Principal Accounting Officer Marc Cobo sold 78 BridgeBio Oncology Therapeutics shares at $2.37 each on Nov. 13, 2026, leaving him with 13,734 shares.




